Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 343 followers

Latest posts

Last updated about 10 hours ago

After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical-stage outfit

about 11 hours ago

After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical-stage...

As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK

about 11 hours ago

As J&J tries to wrap up talc litigation in the US, the...

Calcium+Company enriches comms work with new commercial planning, market access division

about 12 hours ago

Calcium+Company enriches comms work with new commercial planning, market access division apark...

As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact

about 13 hours ago

As other Big Pharmas face local headwinds, Pfizer doubles down on China...

Roche's Vabysmo shows potential to treat eye disorder common in Asia

1 day ago

Roche's Vabysmo shows potential to treat eye disorder common in Asia kdunleavy...

Meet 2024’s fiercest women in life sciences

1 day ago

Meet 2024’s fiercest women in life sciences aellison Thu, 11/21/2024 - 14:07

Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's oncology deal

1 day ago

Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's...

Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reports

1 day ago

Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for...

Novartis, after slimming down, boosts growth projection through the end of the decade

1 day ago

Novartis, after slimming down, boosts growth projection through the end of the...

Biopharma status quo 'likely to persist' under Trump 2.0, though changes to IRA, FTC and more could be on the way: analyst

1 day ago

Biopharma status quo 'likely to persist' under Trump 2.0, though changes to...

Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu

2 days ago

Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and...

On a roll, CDMO Samsung Bio strikes $668M production tie-up with European pharma

2 days ago

On a roll, CDMO Samsung Bio strikes $668M production tie-up with European...